AMR: setting the agenda for change
Official launch of the MEP Interest Group on AMR READ THE PRESS RELEASE
19 February 2020
16.00 - 18.00
European Parliament
The global threat of AMR is not only a serious cross-border health challenge, directly affecting the lives of all Europeans but also threatens global economic development and the achievement of the Sustainable Development Goals.
The European Parliament can play a key role in boosting actions to tackle AMR at EU level. The MEP Interest Group on AMR offers a unique opportunity to address AMR. This first official meeting kickstarted the activities of the MEP Interest Group on AMR for the parliamentary term 2019-2024.
Re-live the event
Event Gallery
Opening remarks
Press Release
Programme
16:00 - 16:10 Welcome
16:10 - 16:25 Opening remarks
16:25 - 16:35 Living with AMR: A personal experience
16:35 - 17:00 MEPs fight AMR: Strategic work programme
17:00 - 17:20 Reactions from the audience
17:20 - 17:30 Closing remarks
17:30 - 18:00 Cocktail reception
The debate on social media
#AMR presents significant human & economic cost & increases pressure on healthcare systems. Our response requires action across sectors. Look forward to working with @Europarl_EN Interest Group on Antimicrobial Resistance on this vital issue. #MEPvsAMR https://t.co/MYj9HHwmTr pic.twitter.com/FjHarpEppn
— Stella Kyriakides (@SKyriakidesEU) February 19, 2020
AMR is 1 of the greatest #publichealth threats with significant human & economic costs@SKyriakidesEU told the MEP Interest Group on #AntimicrobialResistance.
— EU_Health (@EU_Health) February 19, 2020
We face an uphill struggle if we don't stop AMR in its tracks & take effective action.#MEPvsAMRhttps://t.co/sEIm1zHkHS pic.twitter.com/NnKgJEttxY
Congratulations on the launch of the #MEPvsAMR Interest Group. As @FAO we are looking forward to continuing our work with the @EU_Commission, European Parliamentarians and other stakeholders on #AntiMicrobialResistance ?. pic.twitter.com/CwXA18aVng
— FAO Brussels (@FAOBrussels) February 20, 2020
"I think it’s important to raise awareness against #AMR. It’s very important for us that people fight against it. Please do all your best, because we need it." says Silviu Ciocanelli, patient and musician #MEPvsAMR pic.twitter.com/9TyNzJtOnN
— EPHA (@EPHA_EU) February 19, 2020
It is an honour to be present in the laungh of #MEPvsAMR and be part of this group to bring awareness and push forward the fight against #AMR, and important #publichealth threat @HCWHEuropa @EPHA_EU @SKyriakidesEU1 @TheProgressives pic.twitter.com/SJQEwjeY8N
— Sara Cerdas (@sara_saracerdas) February 19, 2020
Hosted by
Sarah Wiener, MEP
Chair of the MEP Interest Group on AMR
Greens/EFA, Austria
Tiemo Wölken, MEP
Vice-Chair of the MEP Interest Group on AMR
S&D, Germany
Nicolae Ştefănuţă, MEP
Vice-Chair of the MEP Interest Group on AMR
RE, Romania
Speakers
Stella Kyriakides
EU Commissioner for Health and Food Safety
Silviu Ciocanelli
Musician, Colectiv fire survivor
Herman Goossens
Professor of Medical Microbiology at the University of Antwerp
About the MEP Interest Group on Antimicrobial Resistance
Contact
The Secretariat of the Interest Group is supported by the AMR Stakeholder Network and co-hosted by the European Public Health Alliance (EPHA), which leads the AMR Stakeholder Network, and Health Care Without Harm (HCWH) Europe, which is a member of the Network.
Zoltán Massay-Kosubek
Policy Manager European Public Health Alliance zoltan@epha.org
Jean-Yves Stenuick
Pharmaceuticals Policy & Projects Officer Health Care Without Harm (HCWH) Europe jean-yves.stenuick@hcwh.org +32 2503 3137
The European Public Health Alliance has received funding under an operating grant from the European Union’s Health Programme (2014-2020). The content of this website represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the European Health and Digital Executive Agency (HaDEA) or any other body of the European Union. The European Commission and the Agency do not accept any responsibility for use that may be made of the information it contains.
HCWH Europe gratefully acknowledges the financial support of the European Commission (EC)’s LIFE programme. HCWH Europe is solely responsible for the content of this project and related materials. The views expressed do not reflect the official views of the EC.
